FF:11886-125D5: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity= | |sample_ethnicity= | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;2.02648695932075e-293!GO:0005737;cytoplasm;2.31229628627612e-120!GO:0043227;membrane-bound organelle;5.49950887375937e-103!GO:0043231;intracellular membrane-bound organelle;8.56788790253774e-103!GO:0043226;organelle;1.27351758340536e-95!GO:0043229;intracellular organelle;5.3338911115406e-95!GO:0005515;protein binding;2.90701411611265e-81!GO:0044444;cytoplasmic part;5.91682233637859e-75!GO:0044422;organelle part;3.25903688340288e-65!GO:0044446;intracellular organelle part;7.95123480739112e-64!GO:0044237;cellular metabolic process;3.99877268109356e-60!GO:0032991;macromolecular complex;3.79285723994043e-59!GO:0044238;primary metabolic process;4.6321879912804e-59!GO:0043170;macromolecule metabolic process;4.28075275758387e-57!GO:0003723;RNA binding;4.7037444093074e-55!GO:0030529;ribonucleoprotein complex;2.22242016643493e-49!GO:0019538;protein metabolic process;9.24479337853191e-49!GO:0044428;nuclear part;4.81488551808181e-46!GO:0044267;cellular protein metabolic process;8.28869654964875e-46!GO:0044260;cellular macromolecule metabolic process;1.24692549168923e-45!GO:0005634;nucleus;8.26662553433044e-43!GO:0006412;translation;9.78318327936796e-42!GO:0033036;macromolecule localization;4.70677443591688e-40!GO:0015031;protein transport;3.6655028676081e-39!GO:0045184;establishment of protein localization;5.98711908090401e-39!GO:0008104;protein localization;4.01964813936111e-37!GO:0043233;organelle lumen;1.67871926781538e-36!GO:0031974;membrane-enclosed lumen;1.67871926781538e-36!GO:0005829;cytosol;2.56351901101845e-36!GO:0012501;programmed cell death;1.12166711211813e-35!GO:0006915;apoptosis;1.12166711211813e-35!GO:0008219;cell death;2.36085312291823e-34!GO:0016265;death;2.36085312291823e-34!GO:0009059;macromolecule biosynthetic process;3.87900527127231e-32!GO:0016071;mRNA metabolic process;6.14110284698578e-31!GO:0043234;protein complex;2.03413732272112e-30!GO:0006396;RNA processing;2.039150301396e-30!GO:0043283;biopolymer metabolic process;2.039150301396e-30!GO:0009058;biosynthetic process;8.35044789648207e-30!GO:0031090;organelle membrane;9.17395523011457e-30!GO:0031981;nuclear lumen;2.39293631339503e-29!GO:0044249;cellular biosynthetic process;6.06258407790681e-29!GO:0010467;gene expression;5.27197996216015e-28!GO:0016043;cellular component organization and biogenesis;7.07535793278231e-28!GO:0008380;RNA splicing;1.610187997656e-27!GO:0046907;intracellular transport;5.34591064935014e-27!GO:0006886;intracellular protein transport;1.26785050237013e-26!GO:0006397;mRNA processing;3.71014873285544e-26!GO:0005840;ribosome;3.09836333732993e-25!GO:0042981;regulation of apoptosis;3.40495378706387e-23!GO:0003735;structural constituent of ribosome;3.56391342483392e-23!GO:0043067;regulation of programmed cell death;6.56194458134092e-23!GO:0005830;cytosolic ribosome (sensu Eukaryota);2.59840477230905e-22!GO:0005739;mitochondrion;3.46244988011516e-22!GO:0000166;nucleotide binding;3.56958862826009e-22!GO:0031967;organelle envelope;4.26894343239881e-22!GO:0033279;ribosomal subunit;4.29905646296587e-22!GO:0008134;transcription factor binding;5.14736354636532e-22!GO:0031975;envelope;7.00722656995154e-22!GO:0044445;cytosolic part;2.04133005453237e-21!GO:0007243;protein kinase cascade;3.86131046323011e-21!GO:0005681;spliceosome;4.52265804024608e-21!GO:0005654;nucleoplasm;4.87370488335518e-21!GO:0065003;macromolecular complex assembly;2.86850888063166e-20!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;3.57813160840901e-20!GO:0051649;establishment of cellular localization;3.6198647505339e-20!GO:0002376;immune system process;1.30628914241202e-19!GO:0051641;cellular localization;1.8709122414751e-19!GO:0048523;negative regulation of cellular process;5.0451136268425e-19!GO:0044451;nucleoplasm part;6.53795986718007e-18!GO:0016192;vesicle-mediated transport;8.80464258998843e-18!GO:0022613;ribonucleoprotein complex biogenesis and assembly;2.18434803747168e-17!GO:0048519;negative regulation of biological process;3.12947023226154e-17!GO:0007242;intracellular signaling cascade;3.12947023226154e-17!GO:0044429;mitochondrial part;3.95464709051268e-17!GO:0006512;ubiquitin cycle;6.27931436355167e-17!GO:0043412;biopolymer modification;7.8590748416245e-17!GO:0032553;ribonucleotide binding;1.00179152528295e-16!GO:0032555;purine ribonucleotide binding;1.00179152528295e-16!GO:0044265;cellular macromolecule catabolic process;1.14538661699672e-16!GO:0048770;pigment granule;1.9033765389901e-16!GO:0042470;melanosome;1.9033765389901e-16!GO:0022607;cellular component assembly;1.91651357602353e-16!GO:0017111;nucleoside-triphosphatase activity;2.21242811413718e-16!GO:0006955;immune response;2.25553236658636e-16!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;3.58538356680222e-16!GO:0016462;pyrophosphatase activity;3.58538356680222e-16!GO:0043285;biopolymer catabolic process;4.57744601241825e-16!GO:0007249;I-kappaB kinase/NF-kappaB cascade;4.65759759753326e-16!GO:0016817;hydrolase activity, acting on acid anhydrides;5.03713292253336e-16!GO:0017076;purine nucleotide binding;5.64424833077395e-16!GO:0006464;protein modification process;9.39061196691698e-16!GO:0043687;post-translational protein modification;1.72268144365906e-15!GO:0043069;negative regulation of programmed cell death;6.39697429365829e-15!GO:0006119;oxidative phosphorylation;6.39697429365829e-15!GO:0043066;negative regulation of apoptosis;9.25603583407166e-15!GO:0022618;protein-RNA complex assembly;1.39926070839259e-14!GO:0009057;macromolecule catabolic process;1.49985493117909e-14!GO:0019941;modification-dependent protein catabolic process;1.65905919165622e-14!GO:0043632;modification-dependent macromolecule catabolic process;1.65905919165622e-14!GO:0006950;response to stress;1.67934331339897e-14!GO:0006605;protein targeting;2.73151973449708e-14!GO:0016604;nuclear body;3.34217992067748e-14!GO:0065009;regulation of a molecular function;3.87338098822397e-14!GO:0006511;ubiquitin-dependent protein catabolic process;3.87338098822397e-14!GO:0051603;proteolysis involved in cellular protein catabolic process;4.57259694276552e-14!GO:0044257;cellular protein catabolic process;5.52292800257737e-14!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;6.03105219436928e-14!GO:0051246;regulation of protein metabolic process;7.85053728258682e-14!GO:0048522;positive regulation of cellular process;1.10133641166479e-13!GO:0005773;vacuole;1.14835704625682e-13!GO:0006913;nucleocytoplasmic transport;1.64842959379532e-13!GO:0050794;regulation of cellular process;2.24290443152274e-13!GO:0051169;nuclear transport;2.93137057024549e-13!GO:0009615;response to virus;3.11355078976193e-13!GO:0005740;mitochondrial envelope;3.19101561636726e-13!GO:0006366;transcription from RNA polymerase II promoter;3.62787457119155e-13!GO:0044248;cellular catabolic process;3.87904620205726e-13!GO:0016874;ligase activity;4.2161365951398e-13!GO:0003712;transcription cofactor activity;4.37311412817496e-13!GO:0030163;protein catabolic process;5.5626366048678e-13!GO:0006793;phosphorus metabolic process;6.89789301284579e-13!GO:0006796;phosphate metabolic process;6.89789301284579e-13!GO:0048518;positive regulation of biological process;7.64942084070216e-13!GO:0006996;organelle organization and biogenesis;7.97212027820312e-13!GO:0031966;mitochondrial membrane;8.64571202008849e-13!GO:0000502;proteasome complex (sensu Eukaryota);8.79365083639803e-13!GO:0005794;Golgi apparatus;1.70410102143362e-12!GO:0016607;nuclear speck;2.00463264779599e-12!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;2.68544862760682e-12!GO:0006916;anti-apoptosis;3.66558961516612e-12!GO:0008135;translation factor activity, nucleic acid binding;3.84587312243355e-12!GO:0015934;large ribosomal subunit;5.32666991293203e-12!GO:0019866;organelle inner membrane;5.37259604683039e-12!GO:0012505;endomembrane system;6.21684727986889e-12!GO:0005524;ATP binding;6.2210654870152e-12!GO:0032559;adenyl ribonucleotide binding;6.68727848874039e-12!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);6.83872693967393e-12!GO:0000323;lytic vacuole;9.68338307824733e-12!GO:0005764;lysosome;9.68338307824733e-12!GO:0016310;phosphorylation;1.02611809556313e-11!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.0835090827085e-11!GO:0015935;small ribosomal subunit;3.30424067400163e-11!GO:0003676;nucleic acid binding;3.39504214770755e-11!GO:0016070;RNA metabolic process;3.58638294105738e-11!GO:0030554;adenyl nucleotide binding;3.87396511522585e-11!GO:0003743;translation initiation factor activity;5.22834340080295e-11!GO:0009607;response to biotic stimulus;5.79531688713102e-11!GO:0048468;cell development;5.87105063048139e-11!GO:0050789;regulation of biological process;7.2625709528264e-11!GO:0050790;regulation of catalytic activity;1.17015464160498e-10!GO:0006417;regulation of translation;1.34041205028436e-10!GO:0006413;translational initiation;1.4470178136306e-10!GO:0009967;positive regulation of signal transduction;1.45030809793604e-10!GO:0006457;protein folding;1.81984396678387e-10!GO:0006259;DNA metabolic process;2.05363568447964e-10!GO:0005768;endosome;2.06880749937326e-10!GO:0044455;mitochondrial membrane part;2.37667850963311e-10!GO:0006446;regulation of translational initiation;5.02965890847047e-10!GO:0031324;negative regulation of cellular metabolic process;6.31119106784999e-10!GO:0051082;unfolded protein binding;7.45393556828614e-10!GO:0065007;biological regulation;8.8934115577106e-10!GO:0016787;hydrolase activity;1.40940903290364e-09!GO:0005743;mitochondrial inner membrane;1.72591854619727e-09!GO:0004842;ubiquitin-protein ligase activity;1.82416337659039e-09!GO:0005635;nuclear envelope;2.10889412291209e-09!GO:0005730;nucleolus;2.5742101359074e-09!GO:0009056;catabolic process;2.68621426612302e-09!GO:0019787;small conjugating protein ligase activity;2.80376757544784e-09!GO:0008639;small protein conjugating enzyme activity;2.85273794000541e-09!GO:0009889;regulation of biosynthetic process;2.85273794000541e-09!GO:0051186;cofactor metabolic process;3.52721618422701e-09!GO:0043065;positive regulation of apoptosis;3.70318298577638e-09!GO:0043068;positive regulation of programmed cell death;5.89288991623116e-09!GO:0000398;nuclear mRNA splicing, via spliceosome;5.89288991623116e-09!GO:0000375;RNA splicing, via transesterification reactions;5.89288991623116e-09!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;5.89288991623116e-09!GO:0051170;nuclear import;8.09605260140173e-09!GO:0031326;regulation of cellular biosynthetic process;9.10432169508094e-09!GO:0006732;coenzyme metabolic process;1.04444462378535e-08!GO:0017038;protein import;1.15280176790366e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.15490493445074e-08!GO:0005770;late endosome;1.41679557546425e-08!GO:0042623;ATPase activity, coupled;1.50030122546514e-08!GO:0051726;regulation of cell cycle;1.68663175489913e-08!GO:0048193;Golgi vesicle transport;1.73139860223616e-08!GO:0016887;ATPase activity;1.74970959603977e-08!GO:0007049;cell cycle;1.8039636412836e-08!GO:0006606;protein import into nucleus;1.89365672095693e-08!GO:0019829;cation-transporting ATPase activity;1.91216747052162e-08!GO:0005783;endoplasmic reticulum;2.1369359414534e-08!GO:0000074;regulation of progression through cell cycle;2.18615776945515e-08!GO:0009966;regulation of signal transduction;2.39679920417514e-08!GO:0009892;negative regulation of metabolic process;2.63154041504671e-08!GO:0019899;enzyme binding;2.78233219872957e-08!GO:0005746;mitochondrial respiratory chain;2.80529527702012e-08!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;3.59269510491116e-08!GO:0016564;transcription repressor activity;3.67033889730136e-08!GO:0003713;transcription coactivator activity;3.6841118144941e-08!GO:0015986;ATP synthesis coupled proton transport;4.14389863221767e-08!GO:0015985;energy coupled proton transport, down electrochemical gradient;4.14389863221767e-08!GO:0044453;nuclear membrane part;6.07888290533222e-08!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;6.56127347960846e-08!GO:0009055;electron carrier activity;6.857135355671e-08!GO:0009152;purine ribonucleotide biosynthetic process;9.04000311250365e-08!GO:0006917;induction of apoptosis;9.31721234114341e-08!GO:0009150;purine ribonucleotide metabolic process;9.60440258816608e-08!GO:0006163;purine nucleotide metabolic process;9.78021499906552e-08!GO:0006164;purine nucleotide biosynthetic process;1.0062293858881e-07!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.04217955590016e-07!GO:0031965;nuclear membrane;1.05859776827746e-07!GO:0007264;small GTPase mediated signal transduction;1.15370906523512e-07!GO:0006954;inflammatory response;1.15557480364995e-07!GO:0050136;NADH dehydrogenase (quinone) activity;1.15787707207239e-07!GO:0003954;NADH dehydrogenase activity;1.15787707207239e-07!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.15787707207239e-07!GO:0005525;GTP binding;1.43791368721303e-07!GO:0003924;GTPase activity;1.45641942884859e-07!GO:0009259;ribonucleotide metabolic process;1.45743459214575e-07!GO:0012502;induction of programmed cell death;1.46752016775641e-07!GO:0045786;negative regulation of progression through cell cycle;1.54130980432443e-07!GO:0008565;protein transporter activity;2.14449466416182e-07!GO:0016879;ligase activity, forming carbon-nitrogen bonds;2.29377302725202e-07!GO:0016881;acid-amino acid ligase activity;2.72489544273781e-07!GO:0006754;ATP biosynthetic process;2.73816750642348e-07!GO:0006753;nucleoside phosphate metabolic process;2.73816750642348e-07!GO:0004386;helicase activity;2.88350981359718e-07!GO:0043228;non-membrane-bound organelle;3.12426801391987e-07!GO:0043232;intracellular non-membrane-bound organelle;3.12426801391987e-07!GO:0009260;ribonucleotide biosynthetic process;3.23526376481204e-07!GO:0016481;negative regulation of transcription;4.04002671380171e-07!GO:0015078;hydrogen ion transmembrane transporter activity;4.77804506719536e-07!GO:0005774;vacuolar membrane;5.02305240126026e-07!GO:0016044;membrane organization and biogenesis;6.21205641127145e-07!GO:0050657;nucleic acid transport;6.41920876804725e-07!GO:0051236;establishment of RNA localization;6.41920876804725e-07!GO:0050658;RNA transport;6.41920876804725e-07!GO:0008047;enzyme activator activity;7.07874601900192e-07!GO:0009108;coenzyme biosynthetic process;8.10622046995341e-07!GO:0006461;protein complex assembly;1.17109492268698e-06!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;1.17109492268698e-06!GO:0009145;purine nucleoside triphosphate biosynthetic process;1.17109492268698e-06!GO:0006403;RNA localization;1.18167789807625e-06!GO:0009142;nucleoside triphosphate biosynthetic process;1.20553044483689e-06!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.20553044483689e-06!GO:0046034;ATP metabolic process;1.22381154806682e-06!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.23254381861377e-06!GO:0016469;proton-transporting two-sector ATPase complex;1.25110518346291e-06!GO:0008026;ATP-dependent helicase activity;1.33595430776389e-06!GO:0051188;cofactor biosynthetic process;1.33595430776389e-06!GO:0042775;organelle ATP synthesis coupled electron transport;1.34567484845961e-06!GO:0042773;ATP synthesis coupled electron transport;1.34567484845961e-06!GO:0005643;nuclear pore;1.71841928957948e-06!GO:0016563;transcription activator activity;1.8279327612623e-06!GO:0051789;response to protein stimulus;1.84421399243839e-06!GO:0006986;response to unfolded protein;1.84421399243839e-06!GO:0044437;vacuolar part;1.92492871130881e-06!GO:0006325;establishment and/or maintenance of chromatin architecture;2.0509816280127e-06!GO:0005793;ER-Golgi intermediate compartment;2.09152822496411e-06!GO:0006752;group transfer coenzyme metabolic process;2.14986985472135e-06!GO:0006952;defense response;2.36297325325537e-06!GO:0016772;transferase activity, transferring phosphorus-containing groups;2.4219309016707e-06!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;2.4389903242787e-06!GO:0015399;primary active transmembrane transporter activity;2.4389903242787e-06!GO:0009893;positive regulation of metabolic process;2.51883246630175e-06!GO:0009199;ribonucleoside triphosphate metabolic process;2.52058403170126e-06!GO:0009205;purine ribonucleoside triphosphate metabolic process;2.52058403170126e-06!GO:0009144;purine nucleoside triphosphate metabolic process;2.52058403170126e-06!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;2.52058403170126e-06!GO:0030964;NADH dehydrogenase complex (quinone);2.60031534942131e-06!GO:0045271;respiratory chain complex I;2.60031534942131e-06!GO:0005747;mitochondrial respiratory chain complex I;2.60031534942131e-06!GO:0016568;chromatin modification;2.68989583114652e-06!GO:0001816;cytokine production;2.92852526991252e-06!GO:0030099;myeloid cell differentiation;3.02393106352584e-06!GO:0051338;regulation of transferase activity;3.06141117964627e-06!GO:0032561;guanyl ribonucleotide binding;3.12472465019228e-06!GO:0019001;guanyl nucleotide binding;3.12472465019228e-06!GO:0006357;regulation of transcription from RNA polymerase II promoter;4.08990626569813e-06!GO:0005765;lysosomal membrane;4.41534237457063e-06!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;4.95109988508141e-06!GO:0006323;DNA packaging;5.17491963412123e-06!GO:0031982;vesicle;5.29849408706516e-06!GO:0043549;regulation of kinase activity;5.41265880131657e-06!GO:0009141;nucleoside triphosphate metabolic process;5.66610320480543e-06!GO:0044432;endoplasmic reticulum part;5.89539144325659e-06!GO:0044440;endosomal part;5.98127713994963e-06!GO:0010008;endosome membrane;5.98127713994963e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;6.65528765597076e-06!GO:0051028;mRNA transport;7.18285580003268e-06!GO:0006897;endocytosis;7.66965778626778e-06!GO:0010324;membrane invagination;7.66965778626778e-06!GO:0051707;response to other organism;8.2339070002694e-06!GO:0045859;regulation of protein kinase activity;8.45056138468454e-06!GO:0048475;coated membrane;9.42267024118794e-06!GO:0030117;membrane coat;9.42267024118794e-06!GO:0006888;ER to Golgi vesicle-mediated transport;1.04500311013747e-05!GO:0005839;proteasome core complex (sensu Eukaryota);1.09376725150684e-05!GO:0032446;protein modification by small protein conjugation;1.09604079709666e-05!GO:0022402;cell cycle process;1.17893710848938e-05!GO:0043566;structure-specific DNA binding;1.18187871426014e-05!GO:0019222;regulation of metabolic process;1.19652886116828e-05!GO:0003724;RNA helicase activity;1.29172042543935e-05!GO:0045321;leukocyte activation;1.29497544882202e-05!GO:0030120;vesicle coat;1.42648194200459e-05!GO:0030662;coated vesicle membrane;1.42648194200459e-05!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.4692345636282e-05!GO:0046930;pore complex;1.6475440993562e-05!GO:0030097;hemopoiesis;1.70312562414889e-05!GO:0003714;transcription corepressor activity;1.84234995210395e-05!GO:0031980;mitochondrial lumen;1.95546137170225e-05!GO:0005759;mitochondrial matrix;1.95546137170225e-05!GO:0016567;protein ubiquitination;2.0603955679138e-05!GO:0008632;apoptotic program;2.39553493644139e-05!GO:0031988;membrane-bound vesicle;2.52519440493538e-05!GO:0031410;cytoplasmic vesicle;2.58216432089704e-05!GO:0006974;response to DNA damage stimulus;2.68580275958166e-05!GO:0016197;endosome transport;3.13058749705853e-05!GO:0045941;positive regulation of transcription;4.3873883873702e-05!GO:0007050;cell cycle arrest;4.3873883873702e-05!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;4.63554552455413e-05!GO:0043492;ATPase activity, coupled to movement of substances;5.00718695770397e-05!GO:0006401;RNA catabolic process;5.06568213109077e-05!GO:0051336;regulation of hydrolase activity;5.19099481901177e-05!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;5.51314176689766e-05!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.70273311704868e-05!GO:0004298;threonine endopeptidase activity;5.72749822302516e-05!GO:0003697;single-stranded DNA binding;5.98446286859645e-05!GO:0004674;protein serine/threonine kinase activity;6.10574884108937e-05!GO:0016023;cytoplasmic membrane-bound vesicle;6.80113820085959e-05!GO:0031325;positive regulation of cellular metabolic process;6.8393673604092e-05!GO:0005789;endoplasmic reticulum membrane;7.18143544708319e-05!GO:0030695;GTPase regulator activity;7.25243316409605e-05!GO:0031902;late endosome membrane;7.3026531078597e-05!GO:0065002;intracellular protein transport across a membrane;7.63159777892484e-05!GO:0009611;response to wounding;7.68689765000003e-05!GO:0016740;transferase activity;7.74199826833811e-05!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;8.49134949811078e-05!GO:0046822;regulation of nucleocytoplasmic transport;9.25331261621474e-05!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;9.43366349947653e-05!GO:0045893;positive regulation of transcription, DNA-dependent;9.46819765324511e-05!GO:0006402;mRNA catabolic process;0.000101686457028206!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.000102451242191439!GO:0051168;nuclear export;0.00010493413082721!GO:0005083;small GTPase regulator activity;0.000116233824695338!GO:0042254;ribosome biogenesis and assembly;0.000134437420338966!GO:0044431;Golgi apparatus part;0.000144697550309259!GO:0002521;leukocyte differentiation;0.000152717845623246!GO:0051223;regulation of protein transport;0.000155884343541733!GO:0006613;cotranslational protein targeting to membrane;0.000166795802433555!GO:0031252;leading edge;0.000168423810526638!GO:0019221;cytokine and chemokine mediated signaling pathway;0.000198784657065319!GO:0005096;GTPase activator activity;0.000198784657065319!GO:0051276;chromosome organization and biogenesis;0.000201355323752319!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000209775736669073!GO:0006281;DNA repair;0.000214502312047514!GO:0046649;lymphocyte activation;0.00021637038950919!GO:0009060;aerobic respiration;0.000223307876622735!GO:0042110;T cell activation;0.000224475662412194!GO:0030532;small nuclear ribonucleoprotein complex;0.000241156827742805!GO:0046519;sphingoid metabolic process;0.000243005332255733!GO:0005769;early endosome;0.000245709579832381!GO:0045637;regulation of myeloid cell differentiation;0.000269215635667953!GO:0001775;cell activation;0.000271896624517285!GO:0051427;hormone receptor binding;0.000278410057911833!GO:0043085;positive regulation of catalytic activity;0.000281330750402296!GO:0005885;Arp2/3 protein complex;0.000286197493459961!GO:0008186;RNA-dependent ATPase activity;0.00029060859881156!GO:0005798;Golgi-associated vesicle;0.000294215811270269!GO:0007265;Ras protein signal transduction;0.000301606565594276!GO:0007259;JAK-STAT cascade;0.000310550792963048!GO:0048534;hemopoietic or lymphoid organ development;0.000357220332231653!GO:0045892;negative regulation of transcription, DNA-dependent;0.000373158639920558!GO:0022890;inorganic cation transmembrane transporter activity;0.000395377210096638!GO:0005852;eukaryotic translation initiation factor 3 complex;0.000395547395506124!GO:0007041;lysosomal transport;0.000414774727441635!GO:0045259;proton-transporting ATP synthase complex;0.000432034356434362!GO:0046983;protein dimerization activity;0.000439163797000854!GO:0002520;immune system development;0.000445897730015157!GO:0006672;ceramide metabolic process;0.000449107306060302!GO:0035257;nuclear hormone receptor binding;0.000460007162251645!GO:0016773;phosphotransferase activity, alcohol group as acceptor;0.000468672842052717!GO:0008234;cysteine-type peptidase activity;0.000472925206640839!GO:0030036;actin cytoskeleton organization and biogenesis;0.000486131761184328!GO:0005057;receptor signaling protein activity;0.000502970171283763!GO:0000245;spliceosome assembly;0.000557095533257394!GO:0033157;regulation of intracellular protein transport;0.000596245413663577!GO:0042306;regulation of protein import into nucleus;0.000596245413663577!GO:0001817;regulation of cytokine production;0.000623090109637254!GO:0016301;kinase activity;0.000625334709251038!GO:0018193;peptidyl-amino acid modification;0.000625334709251038!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.000625334709251038!GO:0004812;aminoacyl-tRNA ligase activity;0.000625334709251038!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.000625334709251038!GO:0009117;nucleotide metabolic process;0.000690896695371419!GO:0007034;vacuolar transport;0.000749394230657285!GO:0006818;hydrogen transport;0.000772739641533827!GO:0009719;response to endogenous stimulus;0.000811716429250105!GO:0022415;viral reproductive process;0.000816758850778325!GO:0006919;caspase activation;0.000826918973656114!GO:0004004;ATP-dependent RNA helicase activity;0.000833561244326798!GO:0016281;eukaryotic translation initiation factor 4F complex;0.000904208593250942!GO:0015992;proton transport;0.000918363337536583!GO:0043281;regulation of caspase activity;0.000918820247261447!GO:0003729;mRNA binding;0.000925963609593757!GO:0005667;transcription factor complex;0.000971547392695975!GO:0051090;regulation of transcription factor activity;0.000971547392695975!GO:0031323;regulation of cellular metabolic process;0.000980004229131445!GO:0045333;cellular respiration;0.000988794247288268!GO:0007033;vacuole organization and biogenesis;0.000988794247288268!GO:0043038;amino acid activation;0.000988794247288268!GO:0006418;tRNA aminoacylation for protein translation;0.000988794247288268!GO:0043039;tRNA aminoacylation;0.000988794247288268!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00103050154650561!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.00110659057192987!GO:0005741;mitochondrial outer membrane;0.00122295094836815!GO:0043280;positive regulation of caspase activity;0.0012345775360756!GO:0006468;protein amino acid phosphorylation;0.00148475980673582!GO:0019210;kinase inhibitor activity;0.0014887890774624!GO:0004437;inositol or phosphatidylinositol phosphatase activity;0.00152409527926098!GO:0007005;mitochondrion organization and biogenesis;0.00152555323217014!GO:0004860;protein kinase inhibitor activity;0.00154030124096498!GO:0032940;secretion by cell;0.0015706135125542!GO:0005637;nuclear inner membrane;0.00158891360616793!GO:0043623;cellular protein complex assembly;0.00158891360616793!GO:0006612;protein targeting to membrane;0.0015964085699906!GO:0042221;response to chemical stimulus;0.00161151835776155!GO:0051059;NF-kappaB binding;0.00166598082632878!GO:0042990;regulation of transcription factor import into nucleus;0.0017039911682237!GO:0042991;transcription factor import into nucleus;0.0017039911682237!GO:0005099;Ras GTPase activator activity;0.0017039911682237!GO:0005761;mitochondrial ribosome;0.00180053926298366!GO:0000313;organellar ribosome;0.00180053926298366!GO:0002274;myeloid leukocyte activation;0.00180775733933705!GO:0002757;immune response-activating signal transduction;0.00204403241851958!GO:0030218;erythrocyte differentiation;0.00205266129942372!GO:0007040;lysosome organization and biogenesis;0.00208682920834736!GO:0043433;negative regulation of transcription factor activity;0.00222033608354748!GO:0006399;tRNA metabolic process;0.00233035095635328!GO:0001726;ruffle;0.0024394556009178!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.00246508605299136!GO:0009165;nucleotide biosynthetic process;0.00255758880701436!GO:0016072;rRNA metabolic process;0.00255760522114806!GO:0001819;positive regulation of cytokine production;0.00265436860200581!GO:0033673;negative regulation of kinase activity;0.00272481251702502!GO:0006469;negative regulation of protein kinase activity;0.00272481251702502!GO:0000139;Golgi membrane;0.00274945774365273!GO:0000151;ubiquitin ligase complex;0.002838485914993!GO:0016779;nucleotidyltransferase activity;0.00314098525973737!GO:0004197;cysteine-type endopeptidase activity;0.00322026047181644!GO:0006364;rRNA processing;0.00353638542192699!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00355803350041014!GO:0065004;protein-DNA complex assembly;0.00356295433268463!GO:0000165;MAPKKK cascade;0.00365968066604086!GO:0002252;immune effector process;0.00366267432849809!GO:0051187;cofactor catabolic process;0.00366267432849809!GO:0046966;thyroid hormone receptor binding;0.00369253142796214!GO:0008383;manganese superoxide dismutase activity;0.00369508803816046!GO:0001315;age-dependent response to reactive oxygen species;0.00369508803816046!GO:0060090;molecular adaptor activity;0.00374140123097216!GO:0030029;actin filament-based process;0.00390793867685567!GO:0002764;immune response-regulating signal transduction;0.00405359365317045!GO:0051348;negative regulation of transferase activity;0.00408759511018937!GO:0031968;organelle outer membrane;0.00412595130878285!GO:0033116;ER-Golgi intermediate compartment membrane;0.00415402988933136!GO:0016251;general RNA polymerase II transcription factor activity;0.00435193129126666!GO:0043087;regulation of GTPase activity;0.00435193129126666!GO:0008654;phospholipid biosynthetic process;0.0043912788936554!GO:0044262;cellular carbohydrate metabolic process;0.00439695458170864!GO:0008283;cell proliferation;0.00457993036416062!GO:0019904;protein domain specific binding;0.00461004533344143!GO:0042802;identical protein binding;0.00463182087187605!GO:0030658;transport vesicle membrane;0.00465366850757378!GO:0031901;early endosome membrane;0.00466391192340562!GO:0002504;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;0.00478722921115706!GO:0019867;outer membrane;0.00510685359740699!GO:0006611;protein export from nucleus;0.00511549487975671!GO:0032386;regulation of intracellular transport;0.00518431375906187!GO:0002250;adaptive immune response;0.0051930727548777!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.0051930727548777!GO:0045646;regulation of erythrocyte differentiation;0.00524542806475841!GO:0031072;heat shock protein binding;0.00528136382629098!GO:0006099;tricarboxylic acid cycle;0.00534507907464221!GO:0046356;acetyl-CoA catabolic process;0.00534507907464221!GO:0002573;myeloid leukocyte differentiation;0.00565038400720154!GO:0050900;leukocyte migration;0.00574451629014946!GO:0006643;membrane lipid metabolic process;0.00577642303433039!GO:0019220;regulation of phosphate metabolic process;0.00584438194370684!GO:0051174;regulation of phosphorus metabolic process;0.00584438194370684!GO:0051247;positive regulation of protein metabolic process;0.00603311764040836!GO:0030149;sphingolipid catabolic process;0.0061776725574771!GO:0006935;chemotaxis;0.00642903627393134!GO:0042330;taxis;0.00642903627393134!GO:0042107;cytokine metabolic process;0.00648034435071093!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00713576402934033!GO:0008637;apoptotic mitochondrial changes;0.0072288770196289!GO:0048487;beta-tubulin binding;0.00727329340887348!GO:0019882;antigen processing and presentation;0.00757300402293059!GO:0007165;signal transduction;0.00760289150149185!GO:0016791;phosphoric monoester hydrolase activity;0.00776665023213415!GO:0000082;G1/S transition of mitotic cell cycle;0.007863631067494!GO:0002429;immune response-activating cell surface receptor signaling pathway;0.00795488189222396!GO:0045454;cell redox homeostasis;0.00827566213713951!GO:0030134;ER to Golgi transport vesicle;0.00872747497823729!GO:0006091;generation of precursor metabolites and energy;0.00882583225645369!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00919280686781581!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00919280686781581!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00919280686781581!GO:0042089;cytokine biosynthetic process;0.00937588776581797!GO:0031625;ubiquitin protein ligase binding;0.0097449572700485!GO:0009891;positive regulation of biosynthetic process;0.0102187617663897!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.0102199055280977!GO:0030127;COPII vesicle coat;0.0102571850715308!GO:0012507;ER to Golgi transport vesicle membrane;0.0102571850715308!GO:0010468;regulation of gene expression;0.0105821564337355!GO:0003690;double-stranded DNA binding;0.0106971421571125!GO:0030660;Golgi-associated vesicle membrane;0.0107518283423052!GO:0005152;interleukin-1 receptor antagonist activity;0.0111646507715512!GO:0030353;fibroblast growth factor receptor antagonist activity;0.0111646507715512!GO:0045944;positive regulation of transcription from RNA polymerase II promoter;0.0113913357461744!GO:0030258;lipid modification;0.0114200660173326!GO:0042092;T-helper 2 type immune response;0.0116371178764031!GO:0006084;acetyl-CoA metabolic process;0.0116484760281751!GO:0006891;intra-Golgi vesicle-mediated transport;0.0119925275544373!GO:0030118;clathrin coat;0.0126402818317331!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.0126652885272894!GO:0019207;kinase regulator activity;0.0126850081839345!GO:0009109;coenzyme catabolic process;0.0127331190967945!GO:0045639;positive regulation of myeloid cell differentiation;0.0127622188278775!GO:0051345;positive regulation of hydrolase activity;0.0128663795208191!GO:0048500;signal recognition particle;0.0130991707709691!GO:0042108;positive regulation of cytokine biosynthetic process;0.0132949933224195!GO:0008139;nuclear localization sequence binding;0.013310622271411!GO:0051098;regulation of binding;0.0136785793507375!GO:0043621;protein self-association;0.0137118099028007!GO:0004185;serine carboxypeptidase activity;0.0137118099028007!GO:0045727;positive regulation of translation;0.0137118099028007!GO:0033367;protein localization in mast cell secretory granule;0.0137118099028007!GO:0033365;protein localization in organelle;0.0137118099028007!GO:0033371;T cell secretory granule organization and biogenesis;0.0137118099028007!GO:0033373;maintenance of protease localization in mast cell secretory granule;0.0137118099028007!GO:0033375;protease localization in T cell secretory granule;0.0137118099028007!GO:0042629;mast cell granule;0.0137118099028007!GO:0033377;maintenance of protein localization in T cell secretory granule;0.0137118099028007!GO:0033364;mast cell secretory granule organization and biogenesis;0.0137118099028007!GO:0033380;granzyme B localization in T cell secretory granule;0.0137118099028007!GO:0033379;maintenance of protease localization in T cell secretory granule;0.0137118099028007!GO:0033370;maintenance of protein localization in mast cell secretory granule;0.0137118099028007!GO:0033368;protease localization in mast cell secretory granule;0.0137118099028007!GO:0033366;protein localization in secretory granule;0.0137118099028007!GO:0033382;maintenance of granzyme B localization in T cell secretory granule;0.0137118099028007!GO:0033374;protein localization in T cell secretory granule;0.0137118099028007!GO:0048872;homeostasis of number of cells;0.0144261292913313!GO:0030521;androgen receptor signaling pathway;0.0144530374257423!GO:0002768;immune response-regulating cell surface receptor signaling pathway;0.0144564053884293!GO:0003725;double-stranded RNA binding;0.0144564053884293!GO:0030041;actin filament polymerization;0.0144564053884293!GO:0043021;ribonucleoprotein binding;0.0144968026248393!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.0147032397877453!GO:0019079;viral genome replication;0.0147282111697618!GO:0048471;perinuclear region of cytoplasm;0.0149105036891402!GO:0005138;interleukin-6 receptor binding;0.0149929214767465!GO:0051329;interphase of mitotic cell cycle;0.0150529975018542!GO:0008333;endosome to lysosome transport;0.0152784224690805!GO:0015631;tubulin binding;0.0157037197909838!GO:0006352;transcription initiation;0.0157179691159726!GO:0006607;NLS-bearing substrate import into nucleus;0.0158771466185836!GO:0006984;ER-nuclear signaling pathway;0.0159892781218574!GO:0019377;glycolipid catabolic process;0.0160522127303648!GO:0002237;response to molecule of bacterial origin;0.0162208355089646!GO:0051023;regulation of immunoglobulin secretion;0.0162208355089646!GO:0045994;positive regulation of translational initiation by iron;0.0162208355089646!GO:0033549;MAP kinase phosphatase activity;0.0162208355089646!GO:0017017;MAP kinase tyrosine/serine/threonine phosphatase activity;0.0162208355089646!GO:0030155;regulation of cell adhesion;0.0163169388285724!GO:0008286;insulin receptor signaling pathway;0.0166252458883362!GO:0042613;MHC class II protein complex;0.0167072708786184!GO:0005048;signal sequence binding;0.0167804737360015!GO:0030100;regulation of endocytosis;0.0170888961601936!GO:0000209;protein polyubiquitination;0.0177065041449118!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0179447755832637!GO:0004177;aminopeptidase activity;0.0179458774113143!GO:0051092;activation of NF-kappaB transcription factor;0.0179793981453795!GO:0002684;positive regulation of immune system process;0.01798679801712!GO:0008624;induction of apoptosis by extracellular signals;0.0180789093431828!GO:0005070;SH3/SH2 adaptor activity;0.018252924119139!GO:0007162;negative regulation of cell adhesion;0.0183484758967371!GO:0006333;chromatin assembly or disassembly;0.0185221358213712!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0185221358213712!GO:0045047;protein targeting to ER;0.0185221358213712!GO:0000278;mitotic cell cycle;0.0185345634163983!GO:0030133;transport vesicle;0.0186817481961397!GO:0000049;tRNA binding;0.0189564619626035!GO:0051251;positive regulation of lymphocyte activation;0.0191032574394459!GO:0046631;alpha-beta T cell activation;0.0192726093762895!GO:0006665;sphingolipid metabolic process;0.0196075567286191!GO:0030518;steroid hormone receptor signaling pathway;0.0198044096460726!GO:0002682;regulation of immune system process;0.0198639280588814!GO:0051049;regulation of transport;0.0198639280588814!GO:0005813;centrosome;0.0198639280588814!GO:0019955;cytokine binding;0.0199104383414161!GO:0051252;regulation of RNA metabolic process;0.020228599841227!GO:0030098;lymphocyte differentiation;0.0202478313027093!GO:0019058;viral infectious cycle;0.0202755611520425!GO:0019901;protein kinase binding;0.0203946819244591!GO:0000118;histone deacetylase complex;0.0203946819244591!GO:0006458;'de novo' protein folding;0.0204144233087813!GO:0051084;'de novo' posttranslational protein folding;0.0204144233087813!GO:0048002;antigen processing and presentation of peptide antigen;0.0204559367021077!GO:0045045;secretory pathway;0.0206533065759372!GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains.;0.0215522765298795!GO:0002819;regulation of adaptive immune response;0.0215522765298795!GO:0051325;interphase;0.0215751250647123!GO:0042325;regulation of phosphorylation;0.0216660950590694!GO:0005149;interleukin-1 receptor binding;0.0218057519351833!GO:0004722;protein serine/threonine phosphatase activity;0.0218057519351833!GO:0045746;negative regulation of Notch signaling pathway;0.0218980412898358!GO:0051347;positive regulation of transferase activity;0.0219069854746825!GO:0050870;positive regulation of T cell activation;0.022114434065109!GO:0002440;production of molecular mediator of immune response;0.0227326978291753!GO:0030663;COPI coated vesicle membrane;0.022774455557302!GO:0030126;COPI vesicle coat;0.022774455557302!GO:0005484;SNAP receptor activity;0.022774455557302!GO:0045792;negative regulation of cell size;0.022774455557302!GO:0032318;regulation of Ras GTPase activity;0.0227969826316005!GO:0032763;regulation of mast cell cytokine production;0.0235729775851925!GO:0032762;mast cell cytokine production;0.0235729775851925!GO:0042098;T cell proliferation;0.0236593248386921!GO:0042611;MHC protein complex;0.0237300711884492!GO:0003727;single-stranded RNA binding;0.0238887208836469!GO:0030176;integral to endoplasmic reticulum membrane;0.0238947020940251!GO:0019371;cyclooxygenase pathway;0.0240968200259054!GO:0031327;negative regulation of cellular biosynthetic process;0.0246401455088149!GO:0050778;positive regulation of immune response;0.0246401455088149!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.0246401455088149!GO:0050811;GABA receptor binding;0.0246401455088149!GO:0030137;COPI-coated vesicle;0.0249025904683938!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.025137760553449!GO:0002763;positive regulation of myeloid leukocyte differentiation;0.0257067773943849!GO:0030433;ER-associated protein catabolic process;0.0258229625490348!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0258229625490348!GO:0000184;mRNA catabolic process, nonsense-mediated decay;0.0259029856757095!GO:0003702;RNA polymerase II transcription factor activity;0.0259937158127543!GO:0030308;negative regulation of cell growth;0.0261083256722248!GO:0002467;germinal center formation;0.026188719699621!GO:0048146;positive regulation of fibroblast proliferation;0.0263550956054325!GO:0000785;chromatin;0.0269960175301043!GO:0008361;regulation of cell size;0.0274223933297243!GO:0042992;negative regulation of transcription factor import into nucleus;0.0276857821713075!GO:0042308;negative regulation of protein import into nucleus;0.0276857821713075!GO:0046466;membrane lipid catabolic process;0.0276980378435326!GO:0002697;regulation of immune effector process;0.02794927501916!GO:0030693;caspase activity;0.027953028924794!GO:0030031;cell projection biogenesis;0.0279577928047692!GO:0006414;translational elongation;0.0279712559634466!GO:0046479;glycosphingolipid catabolic process;0.0290438957780188!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0290656209867251!GO:0006749;glutathione metabolic process;0.0297366382076696!GO:0042127;regulation of cell proliferation;0.0299246408924894!GO:0051101;regulation of DNA binding;0.0300469730421718!GO:0000339;RNA cap binding;0.0302907800826183!GO:0009890;negative regulation of biosynthetic process;0.0305993048340165!GO:0030217;T cell differentiation;0.0306651678025105!GO:0001776;leukocyte homeostasis;0.0309531815902233!GO:0016363;nuclear matrix;0.0312677324031526!GO:0045936;negative regulation of phosphate metabolic process;0.031313305108295!GO:0042771;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;0.031313305108295!GO:0043022;ribosome binding;0.0313726946950567!GO:0050851;antigen receptor-mediated signaling pathway;0.0313726946950567!GO:0032943;mononuclear cell proliferation;0.0315376690129574!GO:0046651;lymphocyte proliferation;0.0315376690129574!GO:0002224;toll-like receptor signaling pathway;0.031850600373773!GO:0002221;pattern recognition receptor signaling pathway;0.031850600373773!GO:0043407;negative regulation of MAP kinase activity;0.0322773460469645!GO:0048144;fibroblast proliferation;0.0322773460469645!GO:0048145;regulation of fibroblast proliferation;0.0322773460469645!GO:0042348;NF-kappaB import into nucleus;0.0322773460469645!GO:0042345;regulation of NF-kappaB import into nucleus;0.0322773460469645!GO:0042035;regulation of cytokine biosynthetic process;0.0322773460469645!GO:0008320;protein transmembrane transporter activity;0.0322959481980633!GO:0051051;negative regulation of transport;0.0328528609404329!GO:0019965;interleukin binding;0.0333185719050289!GO:0050727;regulation of inflammatory response;0.0335174097740076!GO:0031347;regulation of defense response;0.0335174097740076!GO:0004672;protein kinase activity;0.0339031021106548!GO:0051050;positive regulation of transport;0.0339765328774718!GO:0042326;negative regulation of phosphorylation;0.0344969906195875!GO:0030968;unfolded protein response;0.0346381617717223!GO:0008312;7S RNA binding;0.0351954664161613!GO:0006595;polyamine metabolic process;0.0351954664161613!GO:0008017;microtubule binding;0.0352907149039662!GO:0032760;positive regulation of tumor necrosis factor production;0.0354298517340641!GO:0051091;positive regulation of transcription factor activity;0.035796151809105!GO:0051235;maintenance of localization;0.0361428837772134!GO:0042832;defense response to protozoan;0.0363055022683689!GO:0006367;transcription initiation from RNA polymerase II promoter;0.0363656111231526!GO:0045603;positive regulation of endothelial cell differentiation;0.0363656111231526!GO:0002444;myeloid leukocyte mediated immunity;0.0366288976503025!GO:0002443;leukocyte mediated immunity;0.0370887018332797!GO:0008287;protein serine/threonine phosphatase complex;0.0371223353623653!GO:0006260;DNA replication;0.0371223353623653!GO:0001562;response to protozoan;0.0376205753962781!GO:0006383;transcription from RNA polymerase III promoter;0.0380412837472179!GO:0033674;positive regulation of kinase activity;0.0383941013211345!GO:0046578;regulation of Ras protein signal transduction;0.038930186717219!GO:0043488;regulation of mRNA stability;0.0389904057834435!GO:0043487;regulation of RNA stability;0.0389904057834435!GO:0042088;T-helper 1 type immune response;0.0389904057834435!GO:0030377;U-plasminogen activator receptor activity;0.0394750152279847!GO:0030595;leukocyte chemotaxis;0.0394775633048948!GO:0050776;regulation of immune response;0.0399645911752823!GO:0050671;positive regulation of lymphocyte proliferation;0.0400414724974707!GO:0032946;positive regulation of mononuclear cell proliferation;0.0400414724974707!GO:0035035;histone acetyltransferase binding;0.0402086406007392!GO:0005350;pyrimidine transmembrane transporter activity;0.0403168802305!GO:0015855;pyrimidine transport;0.0403168802305!GO:0015288;porin activity;0.0403168802305!GO:0051056;regulation of small GTPase mediated signal transduction;0.0405440908249215!GO:0015036;disulfide oxidoreductase activity;0.0405440908249215!GO:0019883;antigen processing and presentation of endogenous antigen;0.0405440908249215!GO:0000287;magnesium ion binding;0.0405472126849788!GO:0005869;dynactin complex;0.0407649221942758!GO:0051881;regulation of mitochondrial membrane potential;0.0407691596711242!GO:0005100;Rho GTPase activator activity;0.0409264595123021!GO:0000119;mediator complex;0.0411926405200609!GO:0006405;RNA export from nucleus;0.0416392857411572!GO:0004428;inositol or phosphatidylinositol kinase activity;0.0418985294640558!GO:0016311;dephosphorylation;0.0421477421894614!GO:0030833;regulation of actin filament polymerization;0.0421477421894614!GO:0030503;regulation of cell redox homeostasis;0.0424396566168617!GO:0030867;rough endoplasmic reticulum membrane;0.0426123446536076!GO:0017166;vinculin binding;0.0426444265855687!GO:0046426;negative regulation of JAK-STAT cascade;0.0429348871162304!GO:0017148;negative regulation of translation;0.0429933134912497!GO:0051052;regulation of DNA metabolic process;0.0432255874871352!GO:0043086;negative regulation of catalytic activity;0.0432397484714729!GO:0005815;microtubule organizing center;0.0433907780021897!GO:0006354;RNA elongation;0.0435164731005372!GO:0022884;macromolecule transmembrane transporter activity;0.0435666959258547!GO:0015450;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;0.0435666959258547!GO:0008538;proteasome activator activity;0.043718870526907!GO:0043405;regulation of MAP kinase activity;0.0437741803722936!GO:0000738;DNA catabolic process, exonucleolytic;0.0438486372324842!GO:0006350;transcription;0.0442906586637147!GO:0045926;negative regulation of growth;0.0444372440330323!GO:0030119;AP-type membrane coat adaptor complex;0.0444372440330323!GO:0004704;NF-kappaB-inducing kinase activity;0.045068995329611!GO:0002263;cell activation during immune response;0.0453742197510211!GO:0042093;T-helper cell differentiation;0.0453742197510211!GO:0002366;leukocyte activation during immune response;0.0453742197510211!GO:0002293;alpha-beta T cell differentiation during immune response;0.0453742197510211!GO:0002294;CD4-positive, alpha-beta T cell differentiation during immune response;0.0453742197510211!GO:0002285;lymphocyte activation during immune response;0.0453742197510211!GO:0002292;T cell differentiation during immune response;0.0453742197510211!GO:0002286;T cell activation during immune response;0.0453742197510211!GO:0042405;nuclear inclusion body;0.0454591005641653!GO:0006376;mRNA splice site selection;0.0456221095519822!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0456221095519822!GO:0002718;regulation of cytokine production during immune response;0.0457374029273184!GO:0002367;cytokine production during immune response;0.0457374029273184!GO:0002700;regulation of production of molecular mediator of immune response;0.0457374029273184!GO:0051045;negative regulation of membrane protein ectodomain proteolysis;0.0457393343084316!GO:0051043;regulation of membrane protein ectodomain proteolysis;0.0457393343084316!GO:0008656;caspase activator activity;0.0460677967460487!GO:0005905;coated pit;0.0470617741698761!GO:0042347;negative regulation of NF-kappaB import into nucleus;0.0474585462043044!GO:0051224;negative regulation of protein transport;0.0474794674498525!GO:0009299;mRNA transcription;0.0476553125067119!GO:0046823;negative regulation of nucleocytoplasmic transport;0.0479933696568196!GO:0033033;negative regulation of myeloid cell apoptosis;0.0479933696568196!GO:0001803;regulation of type III hypersensitivity;0.0479933696568196!GO:0032733;positive regulation of interleukin-10 production;0.0479933696568196!GO:0033025;regulation of mast cell apoptosis;0.0479933696568196!GO:0001805;positive regulation of type III hypersensitivity;0.0479933696568196!GO:0033023;mast cell homeostasis;0.0479933696568196!GO:0002431;Fc receptor mediated stimulatory signaling pathway;0.0479933696568196!GO:0033032;regulation of myeloid cell apoptosis;0.0479933696568196!GO:0001802;type III hypersensitivity;0.0479933696568196!GO:0033028;myeloid cell apoptosis;0.0479933696568196!GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;0.0479933696568196!GO:0033026;negative regulation of mast cell apoptosis;0.0479933696568196!GO:0033024;mast cell apoptosis;0.0479933696568196!GO:0030027;lamellipodium;0.0480247820136841!GO:0045576;mast cell activation;0.0480247820136841!GO:0006650;glycerophospholipid metabolic process;0.0488370329782814!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0488762372304214!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0488762372304214!GO:0045089;positive regulation of innate immune response;0.0491981434110326!GO:0045088;regulation of innate immune response;0.0491981434110326!GO:0043071;positive regulation of non-apoptotic programmed cell death;0.049732036623044 | |||
|sample_id=11886 | |sample_id=11886 | ||
|sample_note= | |sample_note= |
Revision as of 17:16, 25 June 2012
Name: | CD14+ monocytes - treated with Salmonella, donor3 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13493
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13493
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.114 |
10 | 10 | 0.0259 |
100 | 100 | 0.966 |
101 | 101 | 0.88 |
102 | 102 | 0.986 |
103 | 103 | 0.271 |
104 | 104 | 0.54 |
105 | 105 | 0.16 |
106 | 106 | 2.20885e-4 |
107 | 107 | 0.157 |
108 | 108 | 0.81 |
109 | 109 | 0.305 |
11 | 11 | 0.155 |
110 | 110 | 0.182 |
111 | 111 | 0.0757 |
112 | 112 | 0.447 |
113 | 113 | 0.379 |
114 | 114 | 0.0235 |
115 | 115 | 0.146 |
116 | 116 | 0.866 |
117 | 117 | 0.0907 |
118 | 118 | 0.205 |
119 | 119 | 0.117 |
12 | 12 | 0.264 |
120 | 120 | 0.837 |
121 | 121 | 0.751 |
122 | 122 | 0.671 |
123 | 123 | 0.365 |
124 | 124 | 0.874 |
125 | 125 | 0.148 |
126 | 126 | 0.233 |
127 | 127 | 0.484 |
128 | 128 | 0.033 |
129 | 129 | 0.383 |
13 | 13 | 0.0846 |
130 | 130 | 0.295 |
131 | 131 | 0.717 |
132 | 132 | 0.126 |
133 | 133 | 0.993 |
134 | 134 | 0.431 |
135 | 135 | 0.79 |
136 | 136 | 0.936 |
137 | 137 | 0.0405 |
138 | 138 | 0.407 |
139 | 139 | 0.0824 |
14 | 14 | 0.535 |
140 | 140 | 0.481 |
141 | 141 | 0.267 |
142 | 142 | 0.244 |
143 | 143 | 0.0276 |
144 | 144 | 0.427 |
145 | 145 | 0.351 |
146 | 146 | 0.77 |
147 | 147 | 0.849 |
148 | 148 | 0.00876 |
149 | 149 | 0.973 |
15 | 15 | 0.149 |
150 | 150 | 0.269 |
151 | 151 | 0.513 |
152 | 152 | 0.334 |
153 | 153 | 0.67 |
154 | 154 | 0.769 |
155 | 155 | 0.873 |
156 | 156 | 0.724 |
157 | 157 | 0.416 |
158 | 158 | 0.0385 |
159 | 159 | 0.273 |
16 | 16 | 0.339 |
160 | 160 | 0.434 |
161 | 161 | 0.347 |
162 | 162 | 0.23 |
163 | 163 | 0.12 |
164 | 164 | 0.125 |
165 | 165 | 0.228 |
166 | 166 | 0.992 |
167 | 167 | 0.294 |
168 | 168 | 0.105 |
169 | 169 | 0.0155 |
17 | 17 | 0.183 |
18 | 18 | 0.0944 |
19 | 19 | 0.522 |
2 | 2 | 0.564 |
20 | 20 | 0.169 |
21 | 21 | 0.68 |
22 | 22 | 0.296 |
23 | 23 | 0.0288 |
24 | 24 | 0.404 |
25 | 25 | 0.535 |
26 | 26 | 0.0529 |
27 | 27 | 0.561 |
28 | 28 | 0.324 |
29 | 29 | 0.307 |
3 | 3 | 0.117 |
30 | 30 | 0.393 |
31 | 31 | 0.756 |
32 | 32 | 0.483 |
33 | 33 | 0.193 |
34 | 34 | 0.67 |
35 | 35 | 0.104 |
36 | 36 | 0.0699 |
37 | 37 | 0.0712 |
38 | 38 | 0.37 |
39 | 39 | 0.777 |
4 | 4 | 0.975 |
40 | 40 | 0.226 |
41 | 41 | 0.0198 |
42 | 42 | 0.315 |
43 | 43 | 0.0218 |
44 | 44 | 0.614 |
45 | 45 | 0.679 |
46 | 46 | 0.199 |
47 | 47 | 0.57 |
48 | 48 | 0.489 |
49 | 49 | 0.123 |
5 | 5 | 0.317 |
50 | 50 | 0.992 |
51 | 51 | 0.572 |
52 | 52 | 0.29 |
53 | 53 | 0.526 |
54 | 54 | 0.469 |
55 | 55 | 0.716 |
56 | 56 | 0.708 |
57 | 57 | 0.806 |
58 | 58 | 0.18 |
59 | 59 | 0.171 |
6 | 6 | 0.764 |
60 | 60 | 0.0307 |
61 | 61 | 0.697 |
62 | 62 | 0.088 |
63 | 63 | 0.489 |
64 | 64 | 0.561 |
65 | 65 | 0.201 |
66 | 66 | 0.334 |
67 | 67 | 0.41 |
68 | 68 | 0.592 |
69 | 69 | 0.224 |
7 | 7 | 0.239 |
70 | 70 | 0.048 |
71 | 71 | 0.031 |
72 | 72 | 0.272 |
73 | 73 | 0.223 |
74 | 74 | 0.0689 |
75 | 75 | 0.166 |
76 | 76 | 0.173 |
77 | 77 | 0.427 |
78 | 78 | 0.116 |
79 | 79 | 0.961 |
8 | 8 | 0.375 |
80 | 80 | 0.189 |
81 | 81 | 0.357 |
82 | 82 | 0.232 |
83 | 83 | 0.0426 |
84 | 84 | 0.0416 |
85 | 85 | 0.0208 |
86 | 86 | 0.0578 |
87 | 87 | 0.542 |
88 | 88 | 0.762 |
89 | 89 | 0.218 |
9 | 9 | 0.311 |
90 | 90 | 0.0852 |
91 | 91 | 0.352 |
92 | 92 | 0.247 |
93 | 93 | 0.496 |
94 | 94 | 0.0972 |
95 | 95 | 0.61 |
96 | 96 | 0.353 |
97 | 97 | 0.535 |
98 | 98 | 0.141 |
99 | 99 | 0.116 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs13493
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000210 human sample
FF:0011109 human CD14-positive monocytes - treated with Salmonella sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000988 (hematopoietic cell)
0000839 (myeloid lineage restricted progenitor cell)
0000548 (animal cell)
0002194 (monopoietic cell)
0000034 (stem cell)
0002032 (hematopoietic oligopotent progenitor cell)
0000763 (myeloid cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000766 (myeloid leukocyte)
0000219 (motile cell)
0000134 (mesenchymal cell)
0000738 (leukocyte)
0002087 (nongranular leukocyte)
0000255 (eukaryotic cell)
0002031 (hematopoietic lineage restricted progenitor cell)
0000576 (monocyte)
0000037 (hematopoietic stem cell)
0000860 (classical monocyte)
0000566 (angioblastic mesenchymal cell)
0000049 (common myeloid progenitor)
0000557 (granulocyte monocyte progenitor cell)
0000837 (hematopoietic multipotent progenitor cell)
0002057 (CD14-positive, CD16-negative classical monocyte)
0002009 (macrophage dendritic cell progenitor)
0000040 (monoblast)
0000559 (promonocyte)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0002371 (bone marrow)
0001474 (bone element)
0002384 (connective tissue)
0000926 (mesoderm)
0000479 (tissue)
0000062 (organ)
0004765 (skeletal element)
0004120 (mesoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0005291 (embryonic tissue)
0006598 (presumptive structure)
0002532 (epiblast (generic))
0002204 (musculoskeletal system)
0001434 (skeletal system)
0002390 (hematopoietic system)
0002193 (hemolymphoid system)
0002405 (immune system)
0003081 (lateral plate mesoderm)
0006603 (presumptive mesoderm)
0003061 (blood island)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA